Envisia

Envisia is engaged in the discovery and development of ocular therapeutics for the critical needs in ophthalmology. Read more

Benjamin Yerxa's photo - President of Envisia

President

Benjamin Yerxa

CEO Approval Rating

75/100

Est. Annual Revenue
Est. Employees
Sector

Update Industry

ENVISIA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Ocular Therapeutix is one of Envisia's top rivals. Ocular Therapeutix was founded in Bedford, Massachusetts} in 2006. Ocular Therapeutix is in the Pharmaceuticals industry. Compared to Envisia, Ocular Therapeutix generates $22.1M more revenue.

EyePoint is Envisia's #2 competitor. EyePoint was founded in 1987, and is headquartered in Watertown, Massachusetts. EyePoint competes in the Pharmaceuticals industry. EyePoint generates $34.3M more revenue vs. Envisia.

ONL is a top competitor of Envisia. ONL's headquarters is in Ann Arbor, Michigan, and was founded in 2006. ONL operates in the Biotechnology industry. ONL generates ∞% of Envisia's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 28 a good estimate for Envisia's Employee count?

Envisia Acquisitions

No recent acquisitions found related to Envisia

Envisia Funding History

Since Envisia was founded in 2013, it has participated in 3 rounds of funding. In total Envisia has raised $46.1M. Envisia's last funding round was on Mar 2016 for a total of $16.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Mar 2016
$16.5M

Canaan Partners

Debt
Sep 2015
$4.6M
Series A
Nov 2013
$25M

Since Envisia was founded in 2013, it has participated in 3 rounds of funding. In total Envisia has raised $46.1M. Envisia's last funding round was on Mar 2016 for a total of $16.5M

Envisia Investments

No recent investments found related to Envisia

Envisia News

February 5, 2017Drug Development Technology

Envisia reports positive interim results from Phase II trial of ENV515 in glaucoma

US-based clinical-stage biotechnology firm Envisia Therapeutics has reported positive interim results... See more »
October 15, 2016BioPortfolio

Envisia Therapeutics To Present At AAO 2016 Annual Meeting

RESEARCH TRIANGLE PARK N.C. Oct. 15 2016 PRNewswire Envisia Therapeutics today announced that Dr. Tho... See more »
July 28, 2016BioSpace

Envisia Therapeutics Announces Presentation At

Life Sciences Jobs ...... See more »

Envisia Press Releases

December 8, 2015PR Newswire

Envisia Therapeutics Appoints William Yelle Executive Chairman

RESEARCH TRIANGLE PARK, N.C., Dec. 8, 2015 /PRNewswire/ -- Envisia Therapeutics, a clinical-stage bio... See more »
November 5, 2015PR NEWSWIRE

Envisia Therapeutics Selected To Present During Drug Delivery Company Showcase At 2015 Ophthalmalogy Innovation Summit

RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2015 /PRNewswire/ -- Envisia Therapeutics today announced that ... See more »
October 6, 2015PR NEWSWIRE

Envisia Therapeutics' Lead Product Candidate, ENV515 (travoprost XR), Achieves Primary Efficacy Endpoint In Phase 2a Glaucoma Clinical Trial

RESEARCH TRIANGLE PARK, N.C., Oct. 6, 2015 /PRNewswire/ -- Envisia Therapeutics, a clinical-stage bio... See more »
June 18, 2015BUSINESS WIRE

Envisia Therapeutics Names Eric Linsley Chief Financial Officer

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Envisia Therapeutics today announced that it has named... See more »
May 1, 2015BUSINESS WIRE

Envisia Therapeutics to Present at ARVO 2015 Annual Meeting

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Envisia Therapeutics today announced that eight poster... See more »
April 15, 2015BUSINESS WIRE

Envisia Therapeutics to Present at the Ophthalmology Innovation Summit

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Envisia Therapeutics today announced that Dr. Benjamin... See more »

Social Media

Envisia Headquarters

627 Davis Dr Suite 300

Morrisville, North Carolina27560

919-973-1440

Driving Directions »

Trending Companies

Envisia Summary

ABOUT

Overview

Envisia is engaged in the discovery and development of ocular therapeutics for the critical needs in ophthalmology. Envisia was founded in 2013. Envisia's headquarters is located in Morrisville, North Carolina, USA 27560. It has raised 46.1M in 3 roun...

CEO

Envisia's President, Benjamin Yerxa, currently has an approval rating of 75%. Envisia's primary competitors are Ocular Therapeutix, EyePoint & ONL.

Frequently Asked Questions about Envisia

  1. When was Envisia founded?

    Envisia was founded in 2013
  2. Who is Envisia's CEO?

    Envisia's CEO is Benjamin Yerxa
  3. How much revenue does Envisia generate?

    Envisia generates $ < 1M in revenue
  4. How much funding does Envisia have?

    Envisia has historically raised $46.1M in funding
  1. Where is Envisia's headquarters?

    Envisia's headquarters is in Morrisville North Carolina, USA
  2. How many employees does Envisia have?

    Envisia has 28 employees
  3. Who are Envisia's competitors?

    Envisia's top competitors are Ocular Therapeutix, EyePoint, ONL